Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
AlphaNine 1,000unit inj vials
0211000J0BBABAF
|
AlphaNine | Dried factor IX fraction | Cardiovascular System | No data available |
|
AlphaNine 500unit inj vials
0211000J0BBAAAE
|
AlphaNine | Dried factor IX fraction | Cardiovascular System | No data available |
|
BeneFIX 1,000unit inf vials
0211000J0BCACAD
|
BeneFIX | Dried factor IX fraction | Cardiovascular System | No data available |
|
BeneFIX 2,000unit inf vials
0211000J0BCADAG
|
BeneFIX | Dried factor IX fraction | Cardiovascular System | No data available |
|
BeneFIX 250unit inf vials
0211000J0BCABAC
|
BeneFIX | Dried factor IX fraction | Cardiovascular System | No data available |
|
BeneFIX 3,000unit inf vials
0211000J0BCAEAH
|
BeneFIX | Dried factor IX fraction | Cardiovascular System | No data available |
|
BeneFIX 500unit inf vials
0211000J0BCAAAB
|
BeneFIX | Dried factor IX fraction | Cardiovascular System | No data available |
|
Haemonine 1,000unit inj vials
0211000J0BGAAAF
|
Haemonine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Haemonine 500unit inj vials
0211000J0BGABAE
|
Haemonine | Dried factor IX fraction | Cardiovascular System | No data available |
|
High Purity Factor IX 1,000unit inj vials
0211000J0AAAFAF
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
High Purity Factor IX 500unit inj vials
0211000J0AAAEAE
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Hipfix 500unit inj vials
0211000J0BDAAAE
|
Hipfix | Dried factor IX fraction | Cardiovascular System | No data available |
|
Mononine 1,000unit inj vials
0211000J0BEABAF
|
Mononine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Mononine 500unit inj vials
0211000J0BEAAAE
|
Mononine | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 1,000unit inf vials
0211000J0AAADAD
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 2,000unit inf vials
0211000J0AAAGAG
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 250unit inf vials
0211000J0AAACAC
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 3,000unit inf vials
0211000J0AAAHAH
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Nonacog alfa 500unit inf vials
0211000J0AAABAB
|
Dried Factor IX Fraction | Dried factor IX fraction | Cardiovascular System | No data available |
|
Replenine-VF 1,000unit inj vials
0211000J0BFABAF
|
Replenine-VF | Dried factor IX fraction | Cardiovascular System | No data available |
|
Replenine-VF 500unit inj vials
0211000J0BFAAAE
|
Replenine-VF | Dried factor IX fraction | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.